Advocacy

  • Geneva, August 7, 2018.

Letter to Dr. Tedros on the WHO Roadmap on Access to Medicines and Vaccines 2019-2023

  • Geneva, July 31, 2018.

Yolse’s Statement Following South Africa’s Decision to Break The Silence on The UN Political Declaration on TB.

  • Geneva, July 5, 2018.

The political declaration of 242 civil society organizations, advocacy groups, academics and individuals at the high-level meeting on noncommunicable diseases regarding high prices that limit access to medicines, diagnostic tools and vaccines.

  • Geneva, June 8, 2018.

The Francophone civil society’s response to the declaration submitted for signature to the Ministers of Health of French-speaking African countries at the international conference on access to quality medicines and other medical products on May 22, 2018, initiated in Geneva by UNAIDS and OIF.

  • Carouge, May 30, 2017.

Yolse’s statement on the election of Dr. Tedros Adhanom Ghebreyesus as head of the World Health Organization (WHO).

  • Carouge, December 7, 2016.

Yolse’s statement to the UNAIDS Program Coordinating Board (PCB).

  • Carouge, November 10, 2016.

Yolse’s statement following the publication of the Lancet Commission Report on Essential Medicines and Universal Health Coverage.

  • Carouge, September 16, 2016.

Yolse’s statement to the publication of the final report of the UN Secretary-General’s High-Level Group

  •  Carouge, May 25, 2016.

Yolse supported by UNAIDS issued a statement inviting Least Developed Countries (LDCs) members of OAPI to explicitly send a letter to the Director of this institution notifying their willingness to implement immediately the 6 November 2015 decision of the Council of TRIPS.

  • Carouge, December 7, 2015.

UNAIDS and UNDP’s joint letter inviting the Director of OAPI to take into consideration the recommendations of the 23 November 2015 workshop on integrating the transitional period for LDCs into the current Bangui Agreement that is being reviewed.